Insider · CIK 0001599324
Jamie Christensen
Files at MRTX (Mirati Therapeutics, Inc.). First filing Dec 19, 2023, latest Jan 18, 2024.
In brief
Jamie Christensen files SEC Form 4 as officer at MRTX (Mirati Therapeutics, Inc.). Since Dec 19, 2023, Jamie Christensen has reported 0 open-market buys worth $0 and 3 open-market sells worth $322k, the latest filed on Jan 18, 2024.
A track record needs three past buys with six months of prices behind them; Jamie Christensen has 0, so none is measured yet.
The newest scored trade: sold $94k of MRTX on Jan 16, 2024, filed Jan 18, 2024, scored 33 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | Mirati Therapeutics, Inc. | $94k 1,597 shares | -1% | - | |
| 32Weak | Mirati Therapeutics, Inc. | $90k 1,531 shares | -1% | - | |
| 34Weak | Mirati Therapeutics, Inc. | $137k 2,387 shares | -2% | - |
Transactions
Every row this insider has filed, 22 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Common Stock | -56,495 | - | - | 98,501 | Jan 23, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Common Stock | -81,480 | - | - | 17,021 | Jan 23, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Common Stock | -17,021 | - | - | 0 | Jan 23, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -1,042 | - | - | 0 | Jan 23, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -20,715 | - | - | 0 | Jan 23, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -8,747 | - | - | 0 | Jan 23, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -12,879 | - | - | 0 | Jan 23, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -13,750 | - | - | 0 | Jan 23, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -40,825 | - | - | 0 | Jan 23, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -5,162 | - | - | 0 | Jan 23, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -74,838 | - | - | 0 | Jan 23, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -1,383 | - | - | 0 | Jan 23, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -28,617 | - | - | 0 | Jan 23, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -2,127 | - | - | 0 | Jan 23, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -43,329 | - | - | 0 | Jan 23, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -1,250 | - | - | 0 | Jan 23, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -58,750 | - | - | 0 | Jan 23, 2024 |
| Jan 16, 2024 | MRTX Mirati Therapeutics, Inc. | SOpen-market sale Common Stock | -966 | $59.02 | $57k | 156,558 | Jan 18, 2024 |
| Jan 16, 2024 | MRTX Mirati Therapeutics, Inc. | SOpen-market sale Common Stock | -631 | $59.02 | $37k | 155,927 | Jan 18, 2024 |
| Jan 4, 2024 | MRTX Mirati Therapeutics, Inc. | SOpen-market sale Common Stock | -1,531 | $58.81 | $90k | 157,135 | Jan 5, 2024 |
| Dec 29, 2023 | MRTX Mirati Therapeutics, Inc. | AGrant or award Common Stock | +17,021 | $58.75 | $1000k | 158,666 | Jan 3, 2024 |
| Dec 18, 2023 | MRTX Mirati Therapeutics, Inc. | SOpen-market sale Common Stock | -2,387 | $57.50 | $137k | 141,645 | Dec 19, 2023 |
Questions about Jamie Christensen
Answered from the filings on this page, as of the latest one.
Is Jamie Christensen buying or selling?
Not in the last 12 months. Jamie Christensen's latest open-market trade on SEC Form 4 was sold $94k of MRTX on Jan 16, 2024.
How did Jamie Christensen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jamie Christensen has 0.
Where does Jamie Christensen file Form 4?
Jamie Christensen has filed Form 4 at MRTX (Mirati Therapeutics, Inc.) as EVP & Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.